Catharos Medical Systems
Latest round
- Series A
Last raised
- Jan 2006
Total raised
- $1.4M
Investors
- 1
About Catharos Medical Systems
Based in the US, founded in 2005, Catharos is a medical device company that is focused on preventing contrast induced nephropathy by removing radio-contrast dye injected during catheterizations from the patient's body prior to the dye reaching the kidneys.
Who invested in Catharos Medical Systems
1 investor across 1 round
See all investors in Catharos Medical Systems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 3, 2006
Amount
$1.4M
Investors
Questions about Catharos Medical Systems
Who invested in Catharos Medical Systems?
Catharos Medical Systems has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Catharos Medical Systems raised?
Catharos Medical Systems has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Catharos Medical Systems last raise money?
Catharos Medical Systems's most recent round on record is a Series A, in Jan 2006.
What does Catharos Medical Systems do?
Based in the US, founded in 2005, Catharos is a medical device company that is focused on preventing contrast induced nephropathy by removing radio-contrast dye injected during catheterizations from the patient's body prior to the dye reaching the kidneys.
Where is Catharos Medical Systems headquartered?
Catharos Medical Systems is headquartered in Los Gatos, US.
Which VCs invest in companies like Catharos Medical Systems?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Catharos Medical Systems's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Catharos Medical Systems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.